Health Care/Hospital

Philips Future Health Index 2025: Delayed care and lost clinical time call for accelerated AI adoption in APAC

* 66% of patients surveyed in APAC are experiencing delays in seeing specialist doctor, with an average waiting time of 47 days * 89% of healthcare professionals believe that AI and predictive analytics can save lives by facilitating earlier interventions * Building trust among patients and ...

2025-06-12 12:00 3423

Introducing FactsR™ by Corti -- the First Clinical Reasoning Layer for Ambient AI in Healthcare

Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and minimizes post-visit edits - transforming passive documentation into active clinical intelligence. COPENHAGEN, Denmark, June 11, 2025 /PRNewswire/ -- Corti, the leading infrastructure layer for bui...

2025-06-11 19:00 1863

MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia

SINGAPORE, June 11, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative ("Asia PGI"), part of the Duke-NUS Centre for Outbreak Preparedness (COP), have recently...

2025-06-11 14:36 2690

Fosun International Receives the "ESG & Sustainability Award" and Two Other Prestigious Honors from Global Banking and Finance Review

HONG KONG, June 11, 2025 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656) was recently notified by the renowned British finance magazine,Global Banking and Finance Review, that it has received three awards: "ESG & Sustainability Awards – Best Sustainable Development Company As...

2025-06-11 14:04 4491

Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer

CHENGDU, China, June 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱®) in combination with the PD-L1 monoclonal antibody tagitanlimab (科泰莱® ) was...

2025-06-11 11:34 2777

USANA Philippines Receives Two AP Stevie Awards

Company recognized for excellence in marketing and sustainability MANILA, Philippines, June 11, 2025 /PRNewswire/ -- USANA Philippines, a leader in health and wellness, has recently been recognized with two silver awards at the recent Asia Pacific Stevie Awards (AP Stevies). The awards highligh...

2025-06-11 08:48 2160

Voltavate Receives A$850,000 in Oversubscribed Pre-Seed Round, Led by Artesian

MELBOURNE, June 11, 2025 /PRNewswire/ -- Voltavate , an early-stage battery tech company, has raised A$850,000 in an oversubscribed pre-seed round led by Artesian, with participation from Investible, Electrifi Ventures, and leading industry angels including John Wood,...

2025-06-11 08:05 2425

Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology

CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from the Phase 1/2 study (KL264-01/MK-2870-001) evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) as monotherapy we...

2025-06-10 23:52 3660

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology. FREMONT, Calif., June 10, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gat...

2025-06-10 21:22 2871

Ambiq Receives Frost & Sullivan's 2025 Global Company of the Year Award for Its Leadership in Healthcare Semiconductor Solutions

Ambiq recognized for pioneering energy-efficient semiconductor solutions that empower next-generation AI-enabled healthcare innovations SAN ANTONIO, June 10, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce thatAmbiq has been awarded the 2025 Global Company of the Year Award in the s...

2025-06-10 21:00 1944

BusinessFocus SME Excellence Awards 2025 Concludes Successfully - "Let Data Speak: Redefining the Future of SMEs"

HONG KONG, June 10, 2025 /PRNewswire/ -- The second annual "BusinessFocus SME Excellence Awards," hosted byPressLogic  - BusinessFocus , successfully concluded on 24 April 2025, recognizing 21 outstanding small and medium-...

2025-06-10 20:42 2314

PolyU Design Show 2025 highlights students' technology-driven innovations

HONG KONG, June 10, 2025 /PRNewswire/ -- The Hong Kong Polytechnic University's School of Design (PolyU Design) is hosting the PolyU Design Show 2025 from 6 June to 8 August. The Show features over 250 innovative solutions developed by undergraduate and master's students, many of which integrate ...

2025-06-10 17:02 3001

ClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore

SINGAPORE, June 10, 2025 /PRNewswire/ -- ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR),Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to create and grow MedT...

2025-06-10 13:45 2754

Wingderm® Strengthens Presence in Asia at IMCAS Asia 2025

BEIJING, June 10, 2025 /PRNewswire/ -- From June 6 to 8, 2025, IMCAS Asia was successfully held inBangkok, Thailand. As one of the world's leading medical aesthetic events, IMCAS Asia brought together the latest developments and trends in the Asian medical aesthetic market. Wingderm® once again ...

2025-06-10 11:00 3373

New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin

SINGAPORE, June 10, 2025 /PRNewswire/ -- DR.CI:LABO™, Japan's clinic-born leading derma-cosmetics brand, unveiled new findings at IMCAS Asia 2025, reaffirming its position as the go-to skincare brand for Asian skin. The data demonstrated the efficacy of VC100 Essence Lotion EX and 377VC Radian...

2025-06-10 10:30 6004

New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss

Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach CHICAGO, June 10, 2025 /PRNewswire/ -- According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), first-time hair restoration ...

2025-06-10 09:00 2666

Linical Celebrates 20 Years of Advancing Clinical Research and Patient Wellbeing

OSAKA, Japan, June 10, 2025 /PRNewswire/ -- Linical, a leader in clinical research services, is proud to celebrate its 20th anniversary — a milestone that reflects two decades of dedication to improving health outcomes through high-quality, patient-centered research. Since its founding in 2005 in...

2025-06-10 09:00 2252

Akesis Biologics Launches MastGut: A Breakthrough Supplement That Uses DUSP10 Enzyme to Support Gut and Colorectal Health

SINGAPORE, June 10, 2025 /PRNewswire/ -- Akesis Biologics, a biotechnology spin-off from the National University of Singapore (NUS), has officially launched its flagship gut health product,MastGut — a pioneering supplement that delivers therapeutic protection directly to the gut. Built on years o...

2025-06-10 08:45 1900

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

PARIS, June 10, 2025 /PRNewswire/ -- As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure—affecting more than 250 million people worldwide— Echosens , the leader in non-invasive liver ...

2025-06-10 06:00 2457

Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study

TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 16, 2025, at New York-Presbyterian/Columbia University Irv...

2025-06-09 18:00 2773
1 ... 101102103104105106107 ... 541